Last 6.31 INR
Change Today -0.29 / -4.39%
Volume 33.0
GTL On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:00 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

gujarat terce laboratories (GTL) Snapshot

Open
6.31
Previous Close
6.60
Day High
6.31
Day Low
6.31
52 Week High
05/26/14 - 13.07
52 Week Low
12/29/14 - 5.57
Market Cap
46.8M
Average Volume 10 Days
1.4K
EPS TTM
0.56
Shares Outstanding
7.4M
EX-Date
--
P/E TM
11.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for GUJARAT TERCE LABORATORIES (GTL)

Related News

No related news articles were found.

gujarat terce laboratories (GTL) Related Businessweek News

No Related Businessweek News Found

gujarat terce laboratories (GTL) Details

Gujarat Terce Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company’s products include of antimicrobials, analgesic/anti-inflammatory and muscle relaxants, antacid/anti-ulcer agents, anti-allergic, anticough and cold, antiemetics, anti-malarials, antiparasitic and antibacterials, enzymes, haematinics, hormones, laxatives, nutritional supplements, steroids, urinary alkalizers, and utrine relaxants. It also offers formulations for cardiac and skin protection; and ayurvedic and psychotropic range of products. The company provides its products in various forms, such as tablets, capsules, oral liquids, ointments, syrups, and injections. It also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India.

Founded in 1985

gujarat terce laboratories (GTL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gujarat terce laboratories (GTL) Key Developments

Gujarat Terce Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and First Half Year Ended September 30, 2014

Gujarat Terce Laboratories Ltd. announced unaudited standalone earnings results for the second quarter and first half year ended September 30, 2014. For the quarter, the company's net sales (net of excise duty) was INR 69.871 million compared to INR 67.690 million for the same period last year. Profit from operations before other income, finance cost and exceptional items was INR 2.121 million compared to INR 3.581 million for the same period last year. Profit from ordinary activities before tax was INR 0.744 million compared to INR 2.475 million for the same period last year. Net profit was INR 0.744 million compared to INR 2.475 million for the same period last year. For the half year, the company's net sales (net of excise duty) was INR 128.004 million compared to INR 113.447 million for the same period last year. Profit from operations before other income, finance cost and exceptional items was INR 2.223 million compared to INR 2.164 million for the same period last year. Profit from ordinary activities before tax was INR 0.213 million compared to INR 0.512 million for the same period last year. Net profit was INR 0.213 million compared to INR 0.512 million for the same period last year.

Gujarat Terce Laboratories Ltd., Board Meeting, Nov 04, 2014

Gujarat Terce Laboratories Ltd., Board Meeting, Nov 04, 2014. Agenda: To consider quarterly results.

Gujarat Terce Laboratories Ltd. Announces Auditor Changes

Gujarat Terce Laboratories Ltd. at the AGM held on September 27, 2014, appointed M/s USS & Associates as Auditors of the Company to fill casual vacancy caused by resignation of M/s Pary & Co. letter dated September 10, 2014 and to hold office from the conclusion of this meeting until the conclusion of 30th annual general meeting of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTL:IN 6.31 INR -0.29

GTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTL.
View Industry Companies
 

Industry Analysis

GTL

Industry Average

Valuation GTL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 8.6x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUJARAT TERCE LABORATORIES, please visit www.gujaratterce.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.